The UK Supreme Court has dismissed Warner-Lambert's appeal concerning pregabalin/Lyrica for use in the treatment of pain and has indicated that the non-statutory plausibility "standard" is here to stay. More to follow...
In a long awaited judgement the UK Supreme Court today confirmed that a second medical use claim is only considered sufficiently disclosed insofar as a patent is considered to make the claimed use plausible.